Eiger BioPharmaceuticals, Inc.
News
Eiger BioPharmaceuticals (NASDAQ:EIGR) Coverage Initiated at StockNews.com
Ticker Report Equities researchers at StockNews.com assumed coverage on shares of Eiger BioPharmaceuticals (NASDAQ:EIGR - Get Free Report) in a report issued on Sunday. The brokerage set a "sell" rating on the...\n more…
Eiger BioPharmaceuticals, Inc.'s (NASDAQ:EIGR) 28% Dip In Price Shows Sentiment Is Matching Revenues
Simply Wall St Eiger BioPharmaceuticals, Inc. ( NASDAQ:EIGR ) shareholders that were waiting for something to happen have been dealt a...\n more…
Silicon Valley biopharmaceutical company files for Chapter 11 bankruptcy
The Mercury News: Health By Jonathan Randles | Bloomberg\nEiger Biopharmaceuticals Inc., a company developing therapies for rare metabolic diseases, has filed for bankruptcy.\nPublicly traded Eiger listed about $38.8 million...\n more…
Eiger BioPharmaceuticals Files for Voluntary Chapter 11 Protection
Globe Newswire Announces Stalking Horse Agreement for the Sale of Zokinvy (lonafarnib) Patient Access to Zokinvy to Continue Uninterrupted PALO ALTO, Calif., April 01, 2024 (GLOBE NEWSWIRE) -- Eiger...\n more…
Eiger BioPharmaceuticals (NASDAQ:EIGR) Receives New Coverage from Analysts at StockNews.com
Ticker Report StockNews.com assumed coverage on shares of Eiger BioPharmaceuticals (NASDAQ:EIGR Free Report) in a report issued on Saturday. The brokerage issued a sell rating on the biotechnology...\n more…